Glycopyrrolate Injection, Solution
Product Images NDC 70121-1698

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70121-1698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Glycopyrrolate Injection Prefilled Syringes 1)

Chemical structure diagram showing two molecular forms of glycopyrrolate, including the bromide salt form, depicted as molecular formulas with rings, hydroxyl groups, and methylated nitrogen atoms.*

FDA Label Image

1 (Glycopyrrolate Injection Prefilled Syringes 10)

Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) solution for injection. The label states it is for intramuscular (IM) or intravenous (IV) use and is a 2 mL single-dose product. Distributed by Amneal Pharmaceuticals LLC with manufacturing information and bar code visible.*

FDA Label Image

1 (Glycopyrrolate Injection Prefilled Syringes 11)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) in a 2 mL prefilled single-dose syringe. The drug is for intramuscular or intravenous use and is preservative free. Distributed by Amneal Pharmaceuticals LLC, made in India. Storage instructions specify 20 to 25°C (68 to 77°F).*

FDA Label Image

2 mL (Glycopyrrolate Injection Prefilled Syringes 12)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) solution for injection. The label indicates it is for intramuscular or intravenous use and includes 12 prefilled single-dose syringes of 2 mL each. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC, the label includes storage and usage instructions along with a barcode and NDC 70121-1699-2.*

FDA Label Image

1 (Glycopyrrolate Injection Prefilled Syringes 2)

An illustration diagram showing a syringe in an outer package. The syringe components are labeled: plunger rod, label (with instruction 'Do not remove'), syringe barrel, luer lock collar (with instruction 'Do not remove'), and syringe tip cap. The diagram highlights the parts of a prefilled syringe with clear labeling instructions.*

FDA Label Image

1 (Glycopyrrolate Injection Prefilled Syringes 3)

An instructional illustration depicting a blister pack containing a single vial, with an arrow pointing to the edge of the transparent cover labeled 'Peel away the transparent cover.' The image demonstrates how to remove the cover from the blister pack containing the glycopyrrolate injection vial.*

FDA Label Image

1 (Glycopyrrolate Injection Prefilled Syringes 4)

An instructional line drawing showing a hand holding a syringe with a safety needle cap being removed or attached. The syringe is partially inserted into a molded plastic packaging tray, indicating preparation or handling of glycopyrrolate injection solution for administration.*

FDA Label Image

1 (Glycopyrrolate Injection Prefilled Syringes 5)

An instructional illustration showing a hand holding a vial and a syringe, demonstrating how to withdraw glycopyrrolate injection solution from the vial into the syringe. The image depicts the proper technique for preparing the medication for intramuscular or intravenous administration.*

FDA Label Image

1 (Glycopyrrolate Injection Prefilled Syringes 6)

An instructional illustration showing a hand holding a vial being inverted above a syringe, indicating the step of drawing glycopyrrolate injection solution into the syringe. The image emphasizes proper technique for preparing the injectable medication before administration.*

FDA Label Image

1 (Glycopyrrolate Injection Prefilled Syringes 7)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL, 1 mL single-dose vial for intramuscular or intravenous use. Distributed by Amneal Pharmaceuticals LLC, made in India. The label includes lot number and expiration date placeholders.*

FDA Label Image

1 (Glycopyrrolate Injection Prefilled Syringes 8)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL, an injection solution provided in a 1 mL prefilled single-dose syringe for intramuscular or intravenous use. The label states it is preservative free and instructs storage at 20 to 25°C. Distributed by Amneal Pharmaceuticals LLC with barcode and lot/expiration fields.*

FDA Label Image

1 mL (Glycopyrrolate Injection Prefilled Syringes 9)

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL solution in prefilled single-dose syringes, intended for intramuscular or intravenous use. The label indicates 12 x 1 mL doses per package. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC. The label includes storage instructions, dosage strength, and usage warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.